Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from HBM Holdings Ltd. ( (HK:2142) ).
HBM Holdings Ltd. has successfully completed the issuance of 76,271,762 subscription shares to AstraZeneca Holdings under a general mandate, raising approximately US$105.3 million in gross proceeds. The net proceeds will be primarily used for pre-clinical discovery and research and development, with a portion allocated for working capital and general corporate purposes, positioning the company for future growth and development in the biotechnology sector.
More about HBM Holdings Ltd.
HBM Holdings Ltd. is a company incorporated in the Cayman Islands, focusing on the biotechnology industry. The company is engaged in pre-clinical discovery and research and development of clinical programs.
YTD Price Performance: 191.94%
Average Trading Volume: 11,043,500
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$5.7B
See more insights into 2142 stock on TipRanks’ Stock Analysis page.